Browsing Tag

BioSolutions

Emergent Biosolutions shares plunge by more than 37% after U.S. cancels deal with Covid vaccine…

Jason Junior Nov 7, 2021

Test tubes are seen in front of a displayed Emergent logo in this illustration taken, May 21, 2021.Dado Ruvic | ReutersEmergent Biosolutions shares plunged by more than 37% on Friday after the company disclosed it "mutually agreed" with the…

Health

Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and…

Jason Junior Oct 15, 2021

GAITHERSBURG, Md., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the first participant dosed in its pivotal phase 3 study evaluating the safety and immunogenicity of the company’s investigational…

Health

Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in…

Jason Junior Aug 25, 2021

NIAID has initiated a Phase 3 clinical trial to evaluate the efficacy and safety of hyperimmune globulin products, including Emergent’s COVID-19 Human Immune Globulin (COVID-HIG), for potential treatment of COVID-19 in adult patients at…

Newer Posts